Thromboangiitis Obliterans [clinicaltrials_resource:4210b1cdb3dca3274b081a35d0304c80]
clinicaltrials:NCT01064206Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan [clinicaltrials:NCT01447550]Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia [clinicaltrials:NCT02089828]Contrast Enhanced Ultrasound and Muscle [clinicaltrials:NCT02128750]
condition [clinicaltrials_vocabulary:condition]
TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation [clinicaltrials:NCT00145262]clinicaltrials:NCT01064206Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease [clinicaltrials:NCT01302015]Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia [clinicaltrials:NCT01446055]Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan [clinicaltrials:NCT01447550]A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease [clinicaltrials:NCT01484574]Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia [clinicaltrials:NCT02089828]Contrast Enhanced Ultrasound and Muscle [clinicaltrials:NCT02128750]
condition browse [clinicaltrials_vocabulary:condition-browse]
TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation [clinicaltrials:NCT00145262]clinicaltrials:NCT01064206Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease [clinicaltrials:NCT01302015]Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia [clinicaltrials:NCT01446055]Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan [clinicaltrials:NCT01447550]A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease [clinicaltrials:NCT01484574]Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia [clinicaltrials:NCT02089828]Contrast Enhanced Ultrasound and Muscle [clinicaltrials:NCT02128750]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Thromboangiitis Obliterans [clinicaltrials_resource:4210b1cdb3dca3274b081a35d0304c80]
Bio2RDF identifier
4210b1cdb3dca3274b081a35d0304c80
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4210b1cdb3dca3274b081a35d0304c80
identifier
clinicaltrials_resource:4210b1cdb3dca3274b081a35d0304c80
title
Thromboangiitis Obliterans
@en
type
label
Thromboangiitis Obliterans [clinicaltrials_resource:4210b1cdb3dca3274b081a35d0304c80]
@en
Thromboangiitis Obliterans